France's Social Security savings on drugs

18 May 2008

The Director of France's National Sickness Insurance Funds (CNAM), Frederic van Roekeghem, has confirmed a fall of 1.8% in the reimbursement of drugs in the first quarter of this year, compared with the like-period of 2007. Speaking to the daily La Tribune, the CNAM's Director explained that "it is probable that the French have adopted a more parsimonious management of their household pharmacy supplies: they first check that they don't have a given medicine before acquiring more of it."

The "franchise effect" is considered to have reduced drug wastage and over-stocking. For prescription drugs, a levy of 0.50 euros ($0.77) per item is collected, with a yearly maximum per patient of 50 euros for all fees.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight